BioVentrix, Inc. (BVXX)

BioVentrix will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

BioVentrix Cash Flow Statement

Financials in millions usd. Fiscal year is January - December.

Millions usd. Fiscal year is Jan - Dec.

Year Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-7.67	-3.85
Depreciation & Amortization	0.05	0.05
Share-Based Compensation	0.14	0.39
Other Operating Activities	1.67	0.7
Operating Cash Flow	-5.81	-2.72
Debt Issued / Paid	5.01	4.71
Financing Cash Flow	5.01	4.71
Net Cash Flow	-0.8	1.99
Free Cash Flow	-5.81	-2.72

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).